TGThe Adult CP Clinical Practice Guideline Working Group
The Adult CP Clinical Practice Guideline Working Group
+4
Aim: To describe the prevalence and incidence of pain, identify prognostic factors for pain, determine psychometric properties of tools to assess pain, and evaluate effectiveness of interventions for reducing pain among adults with cerebral palsy (CP).Method: Six databases were searched to identify studies published since 1990 in any language that met eligibility criteria defined for each objective. Titles, abstracts, and full texts were screened by two independent reviewers.Results: Sixty‐three studies were identified; 47 reporting prevalence, 28 reporting prognostic factors, four reporting psychometric properties, five evaluating intervention effectiveness. Pain prevalence ranged from 24% to 89%. Prevalence was higher among adults with CP than in adults without it. Communication function, sex, and age were prognostic factors for pain prevalence. Numerical, verbal, and pictorial rating scales were valid for assessing pain intensity in adults with CP. Pharmacological and surgical interventions had no effect on pain. An active lifestyle and sports intervention reduced pain in adults with CP compared with usual care.Interpretation: Many adults with CP experience pain, although prevalence estimates vary considerably. The quality of evidence for prognostic factors and interventions is very low to low. There is a lack of evidence about effective pain management among adults with CP.
11 June 2026 in Developmental Medicine & Child Neurology
TGThe Adult CP Clinical Practice Guideline Working Group
The Adult CP Clinical Practice Guideline Working Group
+3
Aim: To describe the burden of, and investigate prognostic factors for, osteoarthritis, osteopenia and/or osteoporosis, spondylosis, and fracture, and to investigate the effectiveness of protocols for monitoring musculoskeletal disorders and interventions for managing osteoarthritis in adults with cerebral palsy (CP). Method: Six databases were searched from 1990 to 30th September 2024. Titles, abstracts, and full texts were screened by two independent reviewers. Results: Forty‐four reports were included. The burden of osteoarthritis, osteoporosis, and fracture was higher in adults with CP than adults without it, although there was only low to moderate certainty in the evidence. The prevalence of osteoarthritis and osteoporosis/osteopenia was higher in female adults than males. Osteoporosis/osteopenia was more prevalent in adults classified in Gross Motor Function Classification System levels IV and V than levels I to III. Monitoring protocols identified progression of scoliosis and hip displacement but no study compared monitoring against no monitoring. There was very low certainty evidence from one study that total hip arthroplasty improves pain and function in adults with CP and osteoarthritis. Interpretation: Adults with CP are at increased risk of developing musculoskeletal disorders. The limited evidence about prognostic factors, effectiveness of protocols for monitoring progression of disorders, and interventions for managing osteoarthritis in adults with CP hinders efforts to minimize the impact of musculoskeletal disorders on people with CP.
10 January 2024 in Developmental Medicine & Child Neurology
Background/Objectives: Disability affects ~15.7 million children and ~67 million adults in the US, yet these individuals are typically under-represented in clinical research. Clinical research has increasingly broadened its focus on health outcomes to include “positive health,” which reflects the capacity of an individual to adapt to challenges and the absence of disease. Methods: A mixed-methods approach is used to investigate disability community perspectives on research inclusion and the use of positive health as an outcome in the context of childhood-onset disability. Results: Nationally, about one-fourth (1/4) of adults with disabilities and parents/caregivers reported participating in non-disability-specific research; overall, ~23% of adults and ~30% of parents/caregivers report exclusion because of disability, despite >80% endorsing health outcomes research. Disability stakeholders unanimously express the need to reframe positive health in a disability context, provide guidance on how to reframe it as a research outcome, and offer a roadmap for improving research inclusion. Conclusions: A paradigm shift in how positive health is framed may enhance its relevance to disabilities. An action plan for researchers is derived as a pragmatic approach to strengthen the relevance, generalizability and impact of their research.